The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): An open-label, randomized, phase 2 study.
 
Wen Zhang
No Relationships to Disclose
 
Chun-Xia Du
No Relationships to Disclose
 
Zhichao Jiang
No Relationships to Disclose
 
Yongkun Sun
No Relationships to Disclose
 
Yibin Xie
No Relationships to Disclose
 
Yuxin Zhong
No Relationships to Disclose
 
Yuelu Zhu
No Relationships to Disclose
 
Liming Jiang
No Relationships to Disclose
 
Lizhou Dou
No Relationships to Disclose
 
Qi Xue
No Relationships to Disclose
 
Kang Shao
No Relationships to Disclose
 
Shugeng Gao
No Relationships to Disclose
 
Chengfeng Wang
No Relationships to Disclose
 
Dongbing Zhao
No Relationships to Disclose
 
Yantao Tian
No Relationships to Disclose
 
Ai-Ping Zhou
Consulting or Advisory Role - Novartis; Pfizer